Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „UGT1A9“
Suchtreffer
Begriffe & Kennungen
Adempas · 4.5 · Concomitant use with CYP1A1, UGT1A1 and UGT1A9 inhibitors From the recombinant CYP isoforms investigated in vi
Eintrag öffnenAdempas · 4.5 · Concomitant use with CYP1A1, UGT1A1 and UGT1A9 inhibitors From the recombinant CYP isoforms investigated in vi
Eintrag öffnenEpidyolex · 4.5 · Cannabidiol is a substrate for UGT1A7, UGT1A9 and UGT2B7. No formal drug-drug interaction studies have been co
Eintrag öffnenEpidyolex · 4.5 · Sensitive UGT1A9 substrates Coadministration of cannabidiol (7.5 mg/kg twice daily) with a single dose of myco
Eintrag öffnenEpidyolex · 4.5 · Sensitive substrates of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, UGT1A9, and UGT2B7 Sensitive CYP1A2 substrate
Eintrag öffnenEvrenzo · 4.5 · Modifiers of CYP2C8 or UGT1A9 activity Roxadustat is a substrate of CYP2C8 and UGT1A9. Co-administration of ro
Eintrag öffnenForxiga · 4.5 · Following coadministration of dapagliflozin with mefenamic acid (an inhibitor of UGT1A9), a 55% increase in da
Eintrag öffnenJaypirca · 4.5 · Pirtobrutinib is primarily metabolised by CYP3A4, UGT1A8, and UGT1A9.
Eintrag öffnenMaviret · 4.5 · Significant inhibition of CYP1A2, CYP2C9, CYP2C19, CYP2D6, UGT1A6, UGT1A9, UGT1A4, UGT2B7, OCT1, OCT2, OAT1, O
Eintrag öffnenMaviret · 4.5 · Significant inhibition of CYP1A2, CYP2C9, CYP2C19, CYP2D6, UGT1A6, UGT1A9, UGT1A4, UGT2B7, OCT1, OCT2, OAT1, O
Eintrag öffnenNexavar · 4.5 · In vitro, sorafenib inhibited glucuronidation via UGT1A1 and UGT1A9. The clinical relevance of this finding is
Eintrag öffnenNexavar · 4.5 · UGT1A1 and UGT1A9 substrates
Eintrag öffnenNubeqa · 4.5 · UGT1A9 inhibitors Darolutamide is a substrate of UGT1A9. No clinically relevant drug-drug interaction is expec
Eintrag öffnenSteglatro · 4.5 · Effects of other medicinal products on the pharmacokinetics of ertugliflozin Metabolism by UGT1A9 and UGT2B7 i
Eintrag öffnenStivarga · 4.5 · 7 Co-administration of a strong UGT1A9 inhibitor (e.g. mefenamic acid, diflunisal, and niflumic acid) during r
Eintrag öffnenStivarga · 4.5 · Inhibitors of CYP3A4 and UGT1A9/inducers of CYP3A4 In vitro data indicate that regorafenib is metabolized by c
Eintrag öffnenStivarga · 4.5 · UGT1A1 and UGT1A9 substrates In vitro data indicate that regorafenib as well as its active metabolite M-2 inhi
Eintrag öffnenUDP-Glucuronosyltransferase 1A9
Eintrag öffnenVerquvo · 4.5 · UGT1A9/1A1 inhibitors Vericiguat is metabolised by UGT1A9 and UGT1A1. Inhibitors of these UGTs may result in i
Eintrag öffnenVerquvo · 4.5 · Vericiguat is eliminated via multiple routes in humans. The dominant route is glucuronidation via UGT1A9 and U
Eintrag öffnen